These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37640548)

  • 21. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
    JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of Bronchopulmonary Dysplasia Among Very Preterm Infants in the United States.
    Jensen EA; Edwards EM; Greenberg LT; Soll RF; Ehret DEY; Horbar JD
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34078747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of sex on the requirement for and outcomes following late postnatal corticosteroid treatment.
    Lee R; Kostina E; Dassios T; Greenough A
    Eur J Pediatr; 2023 Mar; 182(3):1417-1423. PubMed ID: 36692623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the patterns of respiratory support and incidence of bronchopulmonary dysplasia; a single center experience.
    Algarni SS; Ali K; Alsaif S; Aljuaid N; Alzahrani R; Albassam M; Alanazi R; Alqueflie D; Almutairi M; Alfrijan H; Alanazi A; Ghazwani A; Alshareedah S; Alotaibi TF; Alqahtani MM; Aljohani H; Ismaeil TT; Alwadeai KS; Siraj RA; Alsaif A; Asiri S; Halabi S; Alanazi AMM
    BMC Pediatr; 2023 Jul; 23(1):357. PubMed ID: 37442954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of postnatal dexamethasone timing on preterm mortality and bronchopulmonary dysplasia: a propensity score analysis.
    Kwok TC; Szatkowski L; Sharkey D
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37591537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.
    Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E
    JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
    Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
    Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants.
    Moschino L; Nardo D; Bonadies L; Stocchero M; Res G; Priante E; Salvadori S; Baraldi E
    Pediatr Pulmonol; 2021 Jul; 56(7):2114-2124. PubMed ID: 33942570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for moderate/severe bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks: a multicenter retrospective analysis].
    Jiangsu Province Neonatal Perinatal Cooperation Network
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1104-1110. PubMed ID: 36305110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at Birth.
    Shukla VV; Souder JP; Imbrock G; Hu M; Rahman AKMF; Travers CP; Ambalavanan N; Carlo WA; Lal CV
    JAMA Netw Open; 2022 Aug; 5(8):e2229105. PubMed ID: 36036932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
    Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
    BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.